Clinical Research Division, Fred Hutch
Dr. Hannah Linden is associate program director of the Medical Oncology and Hematology Fellowship Program at Fred Hutch and UW Medicine. She is a breast cancer specialist who treats patients at Seattle Cancer Care Alliance, the Hutch’s clinical-care partner, and Harborview Medical Center. Her clinical expertise is in hormone therapy, including treatments that target estrogen receptors. Dr. Linden also studies new breast cancer therapies and molecular imaging techniques, such as using PET scans to confirm the effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer. She is also interested in improving access to care in medically underserved, vulnerable populations.
Professor of Medicine, Medical Oncology Division
University of Washington School of Medicine
Senior Research Fellow, Hematology, University of Washington, 1994-2002
Fellowship, Hematology, University of Washington School of Medicine, 1993-1994
Fellowship, Pharmacology, University of Arizona Medical Center, 1992-1993
Residency, University of Arizona Medical Center, 1989-1992
M.D., University of Massachusetts, 1989
B.A., cum laude, Yale University, 1985
Understanding resistance and sensitivity to endocrine therapy of breast cancer, and identification of methods to overcome resistance
Improving access to clinical trials
Improving outcomes for vulnerable populations
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email email@example.com or call 206.667.2210